A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
PHASE1
The study will evaluate the effect of oral contraceptive (birth control pil...
Status
Withdrawn
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Relative Bioavailability Study to Assess Two Solid Formulations Compared to an Oral Solution of AZD3293 in Healthy Male and Non-Fertile Female Subjects
PHASE1
This is an open-label, randomized, 3-period crossover, single dose study. T...